590 related articles for article (PubMed ID: 9263330)
21. Effect of arbutin on melanogenic proteins in human melanocytes.
Chakraborty AK; Funasaka Y; Komoto M; Ichihashi M
Pigment Cell Res; 1998 Aug; 11(4):206-12. PubMed ID: 9711535
[TBL] [Abstract][Full Text] [Related]
22. Alpha-MSH and other melanogenic activators mediate opposite effects on tyrosinase and dopachrome tautomerase in B16/F10 mouse melanoma cells.
Martínez-Liarte JH; Solano F; García-Borrón JC; Jara JR; Lozano JA
J Invest Dermatol; 1992 Oct; 99(4):435-9. PubMed ID: 1328399
[TBL] [Abstract][Full Text] [Related]
23. The mouse brown (b) locus protein functions as a dopachrome tautomerase.
Winder AJ; Wittbjer A; Odh G; Rosengren E; Rorsman H
Pigment Cell Res; 1994 Oct; 7(5):305-10. PubMed ID: 7886003
[TBL] [Abstract][Full Text] [Related]
24. High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex.
Orlow SJ; Zhou BK; Chakraborty AK; Drucker M; Pifko-Hirst S; Pawelek JM
J Invest Dermatol; 1994 Aug; 103(2):196-201. PubMed ID: 8040609
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1.
Martínez-Esparza M; Jiménez-Cervantes C; Beermann F; Aparicio P; Lozano JA; García-Borrón JC
J Biol Chem; 1997 Feb; 272(7):3967-72. PubMed ID: 9020101
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of melanin monomers, dihydroxyindole-2-carboxylic acid (DHICA) and dihydroxyindole (DHI) on mammalian tyrosinase, with a special reference to the role of DHICA/DHI ratio in melanogenesis.
Wilczek A; Mishima Y
Pigment Cell Res; 1995 Apr; 8(2):105-12. PubMed ID: 7659677
[TBL] [Abstract][Full Text] [Related]
27. The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase.
Olivares C; Jiménez-Cervantes C; Lozano JA; Solano F; García-Borrón JC
Biochem J; 2001 Feb; 354(Pt 1):131-9. PubMed ID: 11171088
[TBL] [Abstract][Full Text] [Related]
28. Tyrosinase stabilization by Tyrp1 (the brown locus protein).
Kobayashi T; Imokawa G; Bennett DC; Hearing VJ
J Biol Chem; 1998 Nov; 273(48):31801-5. PubMed ID: 9822646
[TBL] [Abstract][Full Text] [Related]
29. Metal ligand-binding specificities of the tyrosinase-related proteins.
Furumura M; Solano F; Matsunaga N; Sakai C; Spritz RA; Hearing VJ
Biochem Biophys Res Commun; 1998 Jan; 242(3):579-85. PubMed ID: 9464259
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors.
Curto EV; Kwong C; Hermersdörfer H; Glatt H; Santis C; Virador V; Hearing VJ; Dooley TP
Biochem Pharmacol; 1999 Mar; 57(6):663-72. PubMed ID: 10037452
[TBL] [Abstract][Full Text] [Related]
31. Functional properties of cloned melanogenic proteins.
Hearing VJ; Tsukamoto K; Urabe K; Kameyama K; Montague PM; Jackson IJ
Pigment Cell Res; 1992 Nov; 5(5 Pt 2):264-70. PubMed ID: 1292007
[TBL] [Abstract][Full Text] [Related]
32. RUTBC1 Functions as a GTPase-activating Protein for Rab32/38 and Regulates Melanogenic Enzyme Trafficking in Melanocytes.
Marubashi S; Shimada H; Fukuda M; Ohbayashi N
J Biol Chem; 2016 Jan; 291(3):1427-40. PubMed ID: 26620560
[TBL] [Abstract][Full Text] [Related]
33. The amphibian melanization inhibiting factor (MIF) blocks the alpha-MSH effect on mouse malignant melanocytes.
López-Contreras AM; Martínez-Liarte JH; Solano F; Samaraweera P; Newton JM; Bagnara JT
Pigment Cell Res; 1996 Dec; 9(6):311-6. PubMed ID: 9125755
[TBL] [Abstract][Full Text] [Related]
34. Human tyrosinase related protein-1 (TRP-1) does not function as a DHICA oxidase activity in contrast to murine TRP-1.
Boissy RE; Sakai C; Zhao H; Kobayashi T; Hearing VJ
Exp Dermatol; 1998 Aug; 7(4):198-204. PubMed ID: 9758418
[TBL] [Abstract][Full Text] [Related]
35. Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes.
Huang YH; Lee TH; Chan KJ; Hsu FL; Wu YC; Lee MH
J Dermatol Sci; 2008 Feb; 49(2):115-23. PubMed ID: 17766092
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the melanogenesis in human black and light brown melanocytes.
Maeda K; Yokokawa Y; Hatao M; Naganuma M; Tomita Y
J Dermatol Sci; 1997 Mar; 14(3):199-206. PubMed ID: 9138477
[TBL] [Abstract][Full Text] [Related]
37. Biochemical characterization of the melanogenic system in the eye of adult rodents.
Benedito E; Jiménez-Cervantes C; Cubillana JD; Solano F; Lozano JA; García-Borrón JC
Biochim Biophys Acta; 1995 Oct; 1252(2):217-24. PubMed ID: 7578226
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanism for catalysis by a new zinc-enzyme, dopachrome tautomerase.
Solano F; Jiménez-Cervantes C; Martínez-Liarte JH; García-Borrón JC; Jara JR; Lozano JA
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):447-53. PubMed ID: 8573077
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of MSG1 transcriptional co-activator increases melanin in B16 melanoma cells: a possible role for MSG1 in melanogenesis.
Nair SS; Chaubal VA; Shioda T; Coser KR; Mojamdar M
Pigment Cell Res; 2001 Jun; 14(3):206-9. PubMed ID: 11434569
[TBL] [Abstract][Full Text] [Related]
40. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
